P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancer
Article in Pathology - Research and Practice (December 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Combining glycolysis and oxidative stress characterizations to assess prognosis in ovarian cancer
Preprint in Research Square (November 2023)
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment
Article in Cancers (September 2023)